The α1-antichymotrypsin A-allele in German Parkinson disease patients

Journal of Neural Transmission

Volumn 106, Issue 7-8, 1999, Pages 729-736

  Grasbon Frodl, E M ^a   Egensperger, R ^b   Kosel S ^a   Kruger R ^c   Riess, O ^c   Mehraein, P ^a   Graeber, M B ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

Alzheimer disease; Apolipoprotein E; Genetics; Neurodegeneration; Susceptibility allele

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E;

AGED; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GERMANY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; ALLELE; GENETICS; MIDDLE AGED; STATISTICAL MODEL;

AGED; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; APOLIPOPROTEINS E; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 0033286975     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050193     Document Type: Article

References (34)

1. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501
2. Chung H, Roberts CT, Greenberg S, Rebeck GW, Christie R, Wallace R, Jacob HJ, Hyman BT (1996) Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann Neurol 39: 800-803
3. Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB (1995) Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol 90: 257-265
4. Egensperger R, Bancher C, Kösel S, Jellinger K, Mehraein P, Graeber MB (1996) The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions. Biochem Biophys Res Comm 224: 484-486
5. Egensperger R, Kösel S, Schnopp NM, Mehraein P, Graeber MB (1997) Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathol Appl Neurobiol 23: 315-321
6. Egensperger R, Herrmann H, Kösel S, Graeber MB (1998) Association between ACT polymorphism and Alzheimer's disease. Neurology 50: 575
7. Fallin D, Gauntlett AC, Scibelli P, Cai X, Duara R, Gold M, Crawford F, Mullan M (1997) No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Genet Epidemiol 14: 299-305
8. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak Vance MA (1996) No genetic effect of alphal-antichymotrypsin in Alzheimer disease. Genomics 33: 53-56
9. Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R (1994) Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett 182: 1-2
10. Harigaya Y, Shoji M, Nakamura T, Matsubara E, Hosoda K, Hirai S (1995) Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease. Intern Med 34: 481-484
11. Heintz N, Zoghbi H (1997) alpha-Synuclein - a link between Parkinson and Alzheimer diseases? Nature Genet 16: 325-327
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
13. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nature Genet 10: 486-488
14. Kamboh MI, Sanghera DK, Aston CE, Bunker CH, Hamman RF, Ferrell RE, DeKosky ST (1997) Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet Epidemiol 14: 169-180
15. Katzman R, Kang D, Thomas R (1998) Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator. Neurochem Res 23: 369-376
16. Kösel S, Graeber MB (1994) Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol 88: 19-25
17. Kuiper MA, van Kamp GJ, Bergmans PL, Scheltens P, Wolters EC (1993) Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. J Neural Transm [PD-Sect] 6: 145-149
18. Mahieux F, Couderc R, Moulignier A, Bailleul S, Podrabinek N, Laudet J (1995) Isoform 4 of apolipoprotein E and Alzheimer disease. Specificity and clinical study. Rev Neurol 151: 231-239
19. Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwara TM, Lee VM, Hurtig H, Julien JP, Clark C (1995) Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol 90: 239-243
20. Matsubara E, Amari M, Shoji M, Harigaya Y, Yamaguchi H, Okamoto K, Hirai S (1989) Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type. Prog Clin Biol Res 317: 707-714
21. Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ (1998) Alpha-synuclein in neurodegenerative disorders: murderer or accomplice? Nature Med 4: 755-757
22. Müller U, Bodeker RH, Gerundt I, Kurz A (1996) Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E. Neurology 47: 1575-1577
23. Muramatsu T, Matsushita S, Arai H, Sasaki H, Higuchi S (1996) Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J Neural Transm 103: 1205-1210
24. Okuizumi K, Onodera O, Namba Y, Ikeda K, Yamamoto T, Seki K, Ueki A, Nanko S, Tanaka H, Takahashi H, et al (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet 11: 207-209
25. Okuizumi K, Onodera O, Seki K, Tanaka H, Namba Y, Ikeda K, Saunders AM, Pericak Vance MA, Roses AD, Tsuji S (1996) Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol 40: 251-254
26. Pirttila T, Mehta PD, Frey H, Wisniewski HM (1994) Alpha 1-antichymotrypsin and 1L-1 beta are not increased in CSF or serum in Alzheimer's disease. Neurobiol Aging 15: 313-317
27. Poduslo SE, Riggs D, Rolan T, Schwankhaus J (1995) Apolipoprotein E and B alleles in Parkinson's patients. Neurosci Lett 194: 145-147
28. Pritchard ML, Saunders AM, Gaskell PC, Small GW, Conneally PM, Rosi B, Yamaoka LH, Roses AD, Haines JL, Pericak Vance MA (1996) No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci Lett 209: 105-108
29. Rubinsztein DC, Hanlon CS, Irving RM, Goodburn S, Evans DG, Kellar Wood H, Xuereb JH, Bandmann O, Harding AE (1994) Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 8: 519-525
30. nd ed. Cold Spring Harbor Laboratory Press, New York
31. Talbot C, Houlden H, Craddock N, Crook R, Hutton M, Lendon C, Prihar G, Morris JC, Hardy J, Goate A (1996) Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport 7: 534-536
32. Thome J, Baumer A, Kornhuber J, Rösler M, Riederer P (1995) Alpha-1-antichymotrypsin bi-allele polymorphism. apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J Neural Transm (PD-Sect) 10: 207-212
33. Whitehead AS, Bertrandy S, Finnan F, Butler A, Smith GD, Ben-Shlomo Y (1996) Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. J Neurol Neurosurg Psychiatry 61: 347-351
34. Yamamoto M, Kondo I, Ogawa N, Asanuma M, Yamashita Y, Mizuno Y (1997) Genetic association between susceptibility to Parkinson's disease and alpha 1-antichymotrypsin polymorphism. Brain Res 759: 153-155